{"title":"Reconstruction of a Vermilion and Non-vermilion Upper Lip Defect.","authors":"Miranda B An, Jaeeun Lee, Adam M Rotunda","doi":"10.1097/DSS.0000000000005443","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005443","url":null,"abstract":"","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149319051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Outcomes and Patient-Centered Benefits of Fractional Microneedling Radiofrequency for Atrophic Acne Scars: A Retrospective Study.","authors":"Divya Asnani, Shrishti Singh, Asharbh Raman, Priyanka Patil, Sandeep Gopalakrishnan, Aayush Gupta","doi":"10.1097/DSS.0000000000005437","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005437","url":null,"abstract":"<p><strong>Background: </strong>Atrophic acne scars exert a significant psychosocial burden, and management is particularly challenging in darker phototypes because of the heightened risk of pigmentary sequelae.</p><p><strong>Objective: </strong>To evaluate the clinical efficacy, patient satisfaction, and quality-of-life outcomes after fractional microneedling radiofrequency (MNRF) for acne scars.</p><p><strong>Methods: </strong>The authors reviewed medical records of 55 patients (38 males, 17 females) treated with 4 sessions of fractional MNRF between January 2022 and December 2023. Acne scar severity was assessed using the Goodman and Baron quantitative grading scale. Improvement was evaluated by blinded dermatologists using a quartile improvement scale, whereas postprocedure pain and quality of life were assessed via visual analog scale (VAS) and Dermatology Life Quality Index (DLQI), respectively.</p><p><strong>Results: </strong>Mean Goodman-Baron scores fell from 6.88 ± 0.49 to 2.32 ± 0.10 in men and from 5.43 ± 0.44 to 2.37 ± 0.17 in women (both p < .0001). The DLQI improved by 6.85 ± 1.74 points (10.00 → 3.15; p < .0001). All patients achieved at least 25% scar reduction; 42% achieved ≥50%. Mean procedural pain was low (VAS 1.54 ± 0.78), and no serious adverse events or lasting pigmentary changes were observed.</p><p><strong>Conclusion: </strong>A 4-session course of fractional MNRF delivered meaningful scar remodeling and quality-of-life gains with minimal discomfort and downtime, supporting its use as a first-line option for atrophic acne scars in Fitzpatrick phototypes III-V.</p>","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149319044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Platelet-Rich Plasma and Platelet-Based Products in Facial Rejuvenation: State of the Evidence in Skin Quality, Periorbital Aesthetics, and Soft Tissue Augmentation.","authors":"Iesha Ticknor, Katherine M Given, Amelia Hausauer","doi":"10.1097/DSS.0000000000005442","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005442","url":null,"abstract":"<p><strong>Background: </strong>As interest in innovative facial rejuvenation therapies continues to grow, platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) have emerged as promising treatment options.</p><p><strong>Objective: </strong>To review the current medical literature, including efficacy and safety, pertaining to PRP, PRF, and platelet-based products use in facial rejuvenation, both for skin quality and augmentation as monotherapy and in combination with fillers, autologous fat, microneedling, and energy-based devices.</p><p><strong>Methods: </strong>PubMed/MEDLINE and the Cochrane Library were searched through June 2026 for English-language peer-reviewed human studies of platelet-based products in facial rejuvenation; reference lists were hand-searched.</p><p><strong>Results: </strong>The strongest evidence for the use of platelet-based therapies exists in improving overall skin quality, whether alone or in combination with more traditional facial rejuvenation methods. Data for true volume restoration remain more preliminary. Overall, platelet therapies have a satisfactory safety profile. Despite the growing evidence base supporting platelet concentrate efficacy for various indications, overall evidence quality remains poor and unstandardized.</p><p><strong>Conclusion: </strong>Current literature describing use of platelet concentrate in facial rejuvenation and soft tissue augmentation is promising. Substantial variation in product preparation, study design, and reporting measures limits general conclusions and, therefore, widespread adoption of these products in dermatology clinics.</p>","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149319050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tejas P Joshi, Harrison P Nguyen, H William Higgins
{"title":"Conventional Excision of Scrotal Squamous Cell Carcinoma Is Associated With High Rates of Positive Surgical Margins: A National Cancer Database Analysis.","authors":"Tejas P Joshi, Harrison P Nguyen, H William Higgins","doi":"10.1097/DSS.0000000000005428","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005428","url":null,"abstract":"","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149295338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexander D Woods, Umer Nadir, Toan N Vu, Holly Hudson, Joshua L Owen, Aleksandar L Krunic
{"title":"Neoadjuvant Therapy in Mohs Surgery: A Scoping Review of the Literature.","authors":"Alexander D Woods, Umer Nadir, Toan N Vu, Holly Hudson, Joshua L Owen, Aleksandar L Krunic","doi":"10.1097/DSS.0000000000005433","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005433","url":null,"abstract":"<p><strong>Background: </strong>Neoadjuvant therapies are increasingly used before Mohs micrographic surgery (MMS) to shrink tumors and reduce defect size, tumor and surgical invasiveness, and reconstruction complexity. Data on neoadjuvant agents used before MMS, their efficacy, and tolerability are limited.</p><p><strong>Objective: </strong>The aim of this study was to analyze the literature regarding neoadjuvant therapies in MMS, protocols, outcomes, and tolerability.</p><p><strong>Methods: </strong>A scoping review of PubMed, Embase, and Scopus was conducted on July 8th, 2025. Articles related to systemic or local chemotherapeutic and immunotherapeutic agents used neoadjuvantly in MMS were included.</p><p><strong>Results: </strong>Thirty-three studies, including 303 patients, met inclusion criteria. Reports of neoadjuvant vismodegib, sonidegib, and imiquimod in basal cell carcinoma support reduction of the final defect and organ preservation. Reports of neoadjuvant imatinib for dermatofibrosarcoma protuberans show reduction in tumor size. Case reports demonstrated benefits from neoadjuvant talimogene laherparepvec in squamous cell carcinoma and pembrolizumab for desmoplastic melanoma and sebaceous carcinoma.</p><p><strong>Conclusions: </strong>Neoadjuvant therapy can be used before MMS to shrink tumors, decrease surgical defects, and improve cosmetic, functional, and disease outcomes. It should be considered for locally advanced tumors or when preservation of tissue and anatomic function is critical. Larger studies are needed to confirm whether neoadjuvant therapies improve surgical and cosmetic outcomes and reduce recurrence and metastasis.</p>","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149295433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dermatologic SurgeryPub Date : 2026-11-01Epub Date: 2026-05-18DOI: 10.1097/DSS.0000000000005148
Ji-Ye Im, Geon-Jong Lee, Jeong-Hee Kim, Kun Park
{"title":"Surgical Correction of Post-traumatic Onychodystrophy Based on Anatomical Alteration.","authors":"Ji-Ye Im, Geon-Jong Lee, Jeong-Hee Kim, Kun Park","doi":"10.1097/DSS.0000000000005148","DOIUrl":"10.1097/DSS.0000000000005148","url":null,"abstract":"","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":"e194-e196"},"PeriodicalIF":2.3,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147980968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dermatologic SurgeryPub Date : 2026-11-01Epub Date: 2026-06-23DOI: 10.1097/DSS.0000000000005154
Jasmine H Wong, Jennifer M Huang, Emily Y Kim, Bonnie C Carney, Davon T Lee, Rebekah A Allely, Jeffrey W Shupp, Shawn Tejiram, Taryn E Travis
{"title":"Laser-Assisted Drug Delivery of 5-Fluorouracil and Triamcinolone vs. Triamcinolone Monotherapy Does Not Lead to Different Outcomes in the Treatment of Burn Hypertrophic Scars.","authors":"Jasmine H Wong, Jennifer M Huang, Emily Y Kim, Bonnie C Carney, Davon T Lee, Rebekah A Allely, Jeffrey W Shupp, Shawn Tejiram, Taryn E Travis","doi":"10.1097/DSS.0000000000005154","DOIUrl":"10.1097/DSS.0000000000005154","url":null,"abstract":"<p><strong>Background/objective: </strong>Fractional ablative CO 2 laser is an effective treatment for hypertrophic scars (HTS) and can enhance topical drug penetration through laser-assisted drug delivery. Although intralesional triamcinolone is a standard treatment for HTS, it is associated with more adverse effects than topical steroids and has limited applicability for large scars.</p><p><strong>Patients and methods: </strong>This single-institution, prospectively collected, retrospective chart review included 55 patients who underwent laser-assisted drug delivery treatment of either triamcinolone alone or a combination of triamcinolone and 5-fluorouracil. Scars were assessed using 4 subjective scales and objective firmness measurements.</p><p><strong>Results: </strong>Both groups demonstrated significant reductions in scar assessment scores after 3 treatments, but there were no significant differences between the 2 treatment modalities. However, comparisons of baseline with posttreatment scores showed greater improvement in the combination group, suggesting a potential but not statistically significant advantage of combination therapy.</p><p><strong>Conclusion: </strong>Although both groups exhibited improvements in scar outcomes, neither showed significant improvement between groups, suggesting clinical effectiveness without clear superiority. In addition, there were equivocal differences in variables representing adverse effects. Given the comparable efficacy and adverse effects, this study suggests that adding 5-fluorouracil to triamcinolone may not be warranted in laser-assisted drug delivery treatment of hypertrophic scar.</p>","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":"1056-1061"},"PeriodicalIF":2.3,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148293740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dermatologic SurgeryPub Date : 2026-11-01Epub Date: 2026-08-20DOI: 10.1097/DSS.0000000000005325
Faisal R Ali
{"title":"Post-inflammatory Hyperpigmentation After Ablative Laser Resurfacing in Darker Skin: Are Concurrent Retinoids Protective?","authors":"Faisal R Ali","doi":"10.1097/DSS.0000000000005325","DOIUrl":"10.1097/DSS.0000000000005325","url":null,"abstract":"","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":"e196-e197"},"PeriodicalIF":2.3,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148789388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}